Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Eduardo, Cervera"'
Autor:
Jessica Paola Cervantes de la Cruz, Adelina Esther Páez García, Jorge Eduardo Cervera Cárdenas, Leandro Miguel Pérez Gómez
Publikováno v:
Ad-Gnosis, Vol 13, Iss 13, Pp 1-11 (2024)
Introducción: La Inteligencia Artificial (IA), actualmente se ha convertido en la tecnología evolutiva que más está transformando la sociedad, incluyendo los aspectos de enseñanza-aprendizaje en el ámbito de la educación superior; pero esto pu
Externí odkaz:
https://doaj.org/article/858d5b2eef5f42b28f71202bf03fe381
Autor:
Jimena Ylescas‐Soria, Alfredo H. de la Torre‐Lujan, Luis A. Herrera, Daniela Miranda, Flavio Grimaldo, Silvia Rivas, Eduardo Cervera, Abelardo Meneses‐García, Fidias E. Leon-Sarmiento, Diddier Prada
Publikováno v:
Cancer Medicine, Vol 8, Iss 6, Pp 2942-2949 (2019)
Abstract To determine potential predictors of long‐term survival in a large set of Hispanic (Mexican) patients with chronic myeloid leukemia (CML) treated with imatinib. We conducted an analysis with data from 411 patients with CML treated at the N
Externí odkaz:
https://doaj.org/article/f4ae39223b4f4a42a69a6c79a8b73a74
Autor:
Gilberto Barranco Lampon, Itzel Vidal, Dulce Gama, Carlos Martínez, Brenda Acosta, Christian Ramos, Emmanuel Martínez, Juan Zazueta, Irma Olarte, Adolfo Martínez, Eduardo Cervera, Iveth Mendoza, Diana Arcos, Judith Cruz
Purpose: This work aimed to evaluate the impact of a guaranteed access program to Imatinib on the survival of patients with Chronic Myeloid Leukemia Methods: We carried out a retrospective, observational, and analytical study of the database of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbf2bd8d4647e5dd95d38f80f92c2312
https://doi.org/10.21203/rs.3.rs-2779417/v1
https://doi.org/10.21203/rs.3.rs-2779417/v1
Autor:
Roberto Ovilla-Martinez, Xochitl Cota-Rangel, Jose De La Peña-Celaya, Mariana Alejandra Alvarado-Zepeda, Alejandro Jiménez Sastré, Humberto Azuara Forcelledo, Bernardino Ordoñez Rodriguez, Juan Pulido Broca, Aaron Molina Jaimes, Alejandro Muñiz-Carvajal, Maria Magdalena Bahena García, Eduardo Cervera Ceballos, Nidia Paulina Zapata Canto, Jorge Oscar García Mendez, Omar Noel García Jímenez, Jesus Alberto Salas Heredia, Javier Solis Soto, Ruben Alberto Villalobos Mendez, Gregorio Ignacio Ibarra, Cindy Ledesma de la Cruz, Nora Araujo Martinez, Jessi Juárez Lara, Cecilio Omar Ceballos Zuñiga, Felipe Vicente Villaseñor Pérez, Jose Carlos Herrera Garcia, Patricia Nuche Salazar, Alfredo Dominguez Paregrina, Bertha Arizpe Bravo, Gabriela Enciso Figueroa, Teresita Trujillo, Adriana Miguel Álvarez, Diego de Jesús García Gallegos, Alejandro Ortiz Arroyo, Claudia Ivette Solorzano Soto, Hiram Javier Jaramillo Ramírez, Ibis De la Cruz Hernández, Sergio De Gante Martínez, Guadalupe Esmeralda Montesinos Gómez, Silvia Martínez Velasco, Roberto García Graullera, Miguel Angel Vázquez López, Victor Itaí Urbalejo Ceniceros, Yolanda Lugo García, Ana Itamar González Ávila, Jorge Duque Rodriguez, Rodolfo Ruiz Luján, Violeta I. Rodríguez Rivera, Lucio Soberanes Ramírez, Pamela Elena Baez-Islas
Publikováno v:
The Journal of Infection in Developing Countries. 16:63-72
Introduction: Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2) infection is characterised by a viral phase and a severe pro-inflammatory phase. The inhibition of the JAK/STAT pathway limits the pro-inflammatory state in moderate to
Autor:
Davide Rossi, Ritsuro Suzuki, Xavier Badoux, Eduardo Cervera Ceballos, Florence Cymbalista, Alexander Egle, Virginia Abello, Hoa T. T. Tran, Peter Hillmen, Stephen P. Mulligan, Jennifer R. Brown, William G. Wierda, Stephan Stilgenbauer, Yair Herishanu, Teoman Soysal, Andy C. Rawstron, Colin P. Diong, Carsten Utoft Niemann, Shang Ju Wu, Paolo Ghia, Carolyn Owen
Publikováno v:
Wierda, W G, Rawstron, A, Cymbalista, F, Badoux, X, Rossi, D, Brown, J R, Egle, A, Abello, V, Cervera Ceballos, E, Herishanu, Y, Mulligan, S P, Niemann, C U, Diong, C P, Soysal, T, Suzuki, R, Tran, H T T, Wu, S J, Owen, C, Stilgenbauer, S, Ghia, P & Hillmen, P 2021, ' Measurable residual disease in chronic lymphocytic leukemia : expert review and consensus recommendations ', Leukemia, vol. 35, no. 11, pp. 3059-3072 . https://doi.org/10.1038/s41375-021-01241-1
Leukemia
Leukemia
Assessment of measurable residual disease (often referred to as “minimal residual disease”) has emerged as a highly sensitive indicator of disease burden during and at the end of treatment and has been correlated with time-to-event outcomes in ch
Autor:
Juan Antonio Flores-Jiménez, Ruben Solis-Armenta, Guillermo Diaz-Vargas, Eleazar Hernández-Ruiz, Eduardo Cervera, Javier de Jesús Morales-Adrián, Esperanza Barrera, Juan Carlos Solís-Poblano, Oscar Perez, José Luis Álvarez-Vera, Miguel Herrera, Ramiro Espinoza-Zamora, Álvaro Cabrera-García, Eugenia Espitia-Rios, Manuel Solano Manuel, Esthela Juan Lien-Chang Lourdes, Juan Ojeda-Tovar, Juan Manuel Pérez Zúñiga, David Gómez-Almaguer, Cristian Ramos-Penafiel, Alejandro Sosa-Espinoza, Jose Antonio De la Pena, Adrián A. Ceballos-López, Roberta Demichelis, Javier Mijangos, Eva Fabiola Ramirez-Romero, Nidia Zapata-Canto, Martha Alvarado-Ibarra, Manuel Aguilar, Victor Antonio Guillermo, Gladys Gomez-Perdomo, Efren Montano, Luara Arana
Publikováno v:
Journal of Hematology
Background: The present retrospective study reviewed acute promyelocytic leukemia (APL) cases recorded in Mexico between January 2007 and January 2017. The primary objective of the study was to evaluate overall survival (OS) in Mexican patients with
Autor:
Alejandro Sosa-Espinoza, Nidia Zapata-Canto, Jorge Torres-Flores, Eduardo Cervera-Ceballos, Jorge Garcia-Mendez, Ramiro Espinoza-Zamora
Publikováno v:
Journal of Hematology
Background: The main causes of mortality in patients with acute leukemia are the infectious complications. The author wanted to know the induction-related mortality and treatment-related mortality in the acute leukemia patients at the Instituto Nacio
Autor:
Omar Prado-Carrillo, Abner Arenas-Ramírez, Monserrat Llaguno-Munive, Rafael Jurado, Jazmin Pérez-Rojas, Eduardo Cervera-Ceballos, Patricia Garcia-Lopez
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 14; Pages: 7715
Chronic myeloid leukemia (CML) is a hematologic disorder characterized by the oncogene BCR-ABL1, which encodes an oncoprotein with tyrosine kinase activity. Imatinib, a BCR-ABL1 tyrosine kinase inhibitor, performs exceptionally well with minimal toxi
Autor:
Juan Rafael Labardini-Méndez, Eduardo Cervera, Alfonso Dueñas-González, Myrna Candelaria, Jose Ramiro Espinoza-Zamora, Nidia Zapata-Canto, Alejandro Sosa-Espinoza, Magnolia Vieyra-García, Celia López-González, Valentin Lozano-Zavaleta, Diana Vanesa Toledano-Cuevas
Publikováno v:
Expert Opinion on Investigational Drugs. 26:481-487
Objectives To evaluate the activity and safety of hydralazine and valproate (Transkrip) in cutaneous T-cell lymphoma (CTCL). Methods Previously untreated and progressive/refractory CTCL patients received hydralazine at 83 mg or 182 mg/day for slow an
Publikováno v:
Dimensión Empresarial, Vol 14, Iss 2, Pp 184-189 (2016)
El presente ensayo tiene como finalidad presentar una resena de “Economia de la Manipulacion” de George A. Akerlof y Robert J. Shiller, Esta obra muestra como el mercado globalizado esta plagado de trampas y enganos, que realizan las organizacion